Imiquimod

interleukin 1 alpha ; Mus musculus







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34153674 Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation. 2021 Sep 1
2 34171426 Co-delivery of methotrexate and nicotinamide by cerosomes for topical psoriasis treatment with enhanced efficacy. 2021 Aug 10 1
3 34281197 Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice. 2021 Jul 1 2
4 34421919 Mitochondrial Reactive Oxygen Species Are Essential for the Development of Psoriatic Inflammation. 2021 1
5 31932497 Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α. 2020 Feb 15 2
6 32220586 Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay. 2020 May 15 2
7 32512223 Percutaneous absorption of resveratrol and its oligomers to relieve psoriasiform lesions: In silico, in vitro and in vivo evaluations. 2020 Jul 30 1
8 33643287 Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes. 2020 1
9 26147228 IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome. 2015 Oct 1
10 15009713 Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. 2004 Feb 1